Noah Rosenberg Insider Profile
4 Followers
Noah Rosenberg, CMO at Verrica Pharmaceuticals, holds 8.59K shares in Verrica Pharmaceuticals (Ticker: VRCA), holds 0.00 shares in Esperion (Ticker: ESPR), holds 47.61K shares in Travere Therapeutics (Ticker: TVTX). Most recently, Noah Rosenberg Bought ― shares of Verrica Pharmaceuticals on Aug 18, 2026 for an estimated value of $30.61K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+8.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Noah Rosenberg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Noah Rosenberg
Noah Rosenberg's Trading History
Verrica Pharmaceuticals
Aug 18, 2026
CMO
Informative Buy
30.61K
$45.51K
Esperion
―
―
―
$0.00
Travere Therapeutics
Aug 17, 2021
CMO
Uninformative Sell
24.07K
$3.11M
List of latest transactions for each holding click on a transaction to see Noah Rosenberg's performance on stock
You May Also Like
Noah Rosenberg insider profile FAQ
What is the percentage of profitable transactions made by Noah Rosenberg?
The percentage of profitable transactions made by Noah Rosenberg is 100%.
What is the average return per transaction made by Noah Rosenberg?
The average return per transaction made by Noah Rosenberg is 8.30%.
What stocks does Noah Rosenberg hold?
Noah Rosenberg holds: VRCA, ESPR, TVTX stocks.
What was Noah Rosenberg’s latest transaction?
Noah Rosenberg latest transaction was an Informative Buy of $30.61K.
What was Noah Rosenberg's most profitable transaction?
Noah Rosenberg’s most profitable transaction was an Informative Buy of VRCA stock on August 18, 2026. The return on the trade was 13.20%.
What is Noah Rosenberg's role in Verrica Pharmaceuticals?
Noah Rosenberg's role in Verrica Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.